Peer-reviewed veterinary case report
Curcumin may help antibiotics fight resistant Staph infections in dogs
By Byun, William et al.·Published in Veterinary research communications·2026·Veterinary Skin and Ear, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Curcumin shows promise as an adjunct in changing β-lactam susceptibility status of canine multidrug-resistant Staphylococcus pseudintermedius: an in vitro study.
- Species:
- dog
Plain-English summary
A study found that curcumin, a compound from turmeric, may help improve the effectiveness of certain antibiotics against a tough skin infection in dogs caused by multidrug-resistant Staphylococcus pseudintermedius (MDR-SP). This bacteria is often seen in dogs with pyoderma, a type of skin infection. When curcumin was combined with antibiotics like oxacillin and amoxicillin-clavulanate, it made these drugs more effective against the resistant bacteria. While curcumin didn't help with all antibiotics tested, its potential as an additional treatment option is promising and could lead to better outcomes for dogs suffering from these infections.
People also search for: dog skin infection treatment · curcumin for dogs · antibiotic resistance in dogs · pyoderma in dogs · turmeric for dog infections
Abstract
Methicillin-resistant Staphylococcus pseudintermedius (MRSP) has become increasingly widespread in veterinary medicine, with a reported prevalence of up to 40.5% in dogs with pyoderma. Previous studies have shown that curcumin derived from turmeric (Curcuma longa L.) exhibits a synergistic effect when combined with β-lactam antibiotics, fluoroquinolones, tetracyclines, or vancomycin against strains of Staphylococcus aureus, including both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) isolates. Thus, the purpose of this study was to determine whether curcumin (500 µg/mL), in combination with oxacillin, amoxicillin-clavulanate, clindamycin, or doxycycline, could improve the susceptibility status of each antibiotic against multidrug-resistant Staphylococcus pseudintermedius (MDR-SP). Clinical isolates collected from dogs with MDR-SP pyoderma were tested against each antibiotic at their respective Clinical and Laboratory Standards Institute resistant, intermediate, and susceptible concentrations, in the presence or absence of curcumin. An ATCC methicillin-susceptible S. pseudintermedius reference strain (ATCC 49444) was included as an internal quality control. Exact McNemar test was used to assess paired isolate-level comparisons and a value of p < 0.05 was considered significant. A significant shift toward susceptibility was observed when curcumin was combined with oxacillin at the resistant (p = 0.001) and the susceptible (p < 0.0001) concentrations and with amoxicillin-clavulanate at the resistant (p = 0.002) and intermediate (p = 0.0078) concentrations. Amoxicillin-clavulanate at the susceptible concentration when combined with curcumin was not significant (p = 0.0625). Curcumin did not significantly alter the susceptibility status of clindamycin or doxycycline at any of the tested concentrations. Bactericidal concentrations were not observed at the tested concentrations. These results suggest that curcumin may potentiate the efficacy of select β-lactam antibiotics against MDR-SP, supporting curcumin as a potential β-lactam adjuvant against MDR-SP in vitro and warranting further evaluation.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/42126633/